Erdafitinib 4 mg (Erdanat) × 28 Tablets

~~$800.00~~ $390.00

Prescription Required

Erdafitinib is an oral targeted cancer medicine used for selected advanced or metastatic urothelial cancers with susceptible FGFR genetic alterations. Genetic testing is required to determine eligibility, and treatment must be managed by an experienced oncologist.

Generic Name	Erdafitinib
Strength	4 mg
Manufacturer	Natco
Packing	28 Tablets
Prescribed For	Treat adults with advanced or spreading bladder cancer (urothelial carcinoma)
Availability	In Stock
Shipping to	USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Uses of Erdafitinib

Unresectable urothelial cancer
Metastatic bladder or urinary-tract cancer
FGFR-altered tumours after previous treatment

Benefits of Erdafitinib

Targets abnormal FGFR activity
Slows cancer-cell growth
Provides an oral targeted treatment

How Does Erdafitinib Work?

Erdafitinib blocks fibroblast growth factor receptors, particularly abnormal FGFR activity in certain cancer cells. These receptors can continuously send signals that promote uncontrolled cell growth. Blocking them slows the growth and spread of FGFR-altered tumours.

Possible Side Effects

High blood phosphate
Mouth sores
Diarrhoea
Dry mouth or skin
Nail and eye problems

Precautions

FGFR testing is required before treatment.
Regular eye examinations are necessary.
Blood-phosphate levels must be monitored.
Report vision changes immediately.
Avoid pregnancy and breastfeeding.